Please assess the completion status of the following clinical trial:

Trial Title: Tailored Treatment in Metastatic Colorectal Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Metastatic colorectal cancer~* Histopathological verification of the primary tumor~* Measurable disease according to RESIST criteria~* Single agent chemotherapy indicated~* Performance status \>=2~* Age \>= 60 years~* Life expectancy \> 3 months~* Adequate liver and kidney function as evaluated by bilirubin \<= 3 times of normal upper limit, ALAT \<= 3 times upper normal limit (\<= 5 times upper normal limit in case of liver metastases), serum creatinine \<= 1.5 times normal upper limit.~* ANC \>=1.5 x 109/l and platelets \>= 100 x 109/l~* Informed consent~Exclusion Criteria:~* Patients with CNS metastases~* Other malignant disease within the last 5 years except for non-melanoma skin cancer and carcinoma in situ of cervix uteri~* Previous chemotherapy for metastatic disease~* Adjuvant chemotherapy \< 6 months before inclusion~* Patients with previous major toxic or allergic reaction to the protocol drugs

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).